Technical Analysis for NBRV - Nabriva Therapeutics AG

Grade Last Price % Change Price Change
grade B 3.01 -4.44% -0.14
NBRV closed down 4.44 percent on Friday, March 22, 2019, on 1.2 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical NBRV trend table...

Date Alert Name Type % Chg
Mar 22 Slingshot Bullish Bullish Swing Setup 0.00%
Mar 22 Upper Bollinger Band Walk Strength 0.00%
Mar 22 Wide Bands Range Expansion 0.00%
Mar 22 Overbought Stochastic Strength 0.00%
Mar 21 Calm After Storm Range Contraction -4.44%
Mar 21 Upper Bollinger Band Walk Strength -4.44%
Mar 21 Wide Bands Range Expansion -4.44%
Mar 21 Overbought Stochastic Strength -4.44%
Mar 21 Upper Bollinger Band Touch Strength -4.44%
Mar 20 Upper Bollinger Band Walk Strength -5.05%

Older signals for NBRV ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Nabriva Therapeutics AG, a clinical stage biopharmaceutical company, engages in the research and development of anti-infective agents to treat infections in humans. The company focuses on the pleuromutilin class of antibiotics. Its lead product candidate is lefamulin, which has completed a Phase II clinical trial for acute bacterial skin and skin structure infections. The company is developing intravenous and oral formulations of lefamulin for the treatment of community-acquired bacterial pneumonia; and intends to develop lefamulin for additional indications other than pneumonia. It also develops BC-7013, a topical pleuromutilin antibiotic, which has completed a Phase 1 clinical trial. Nabriva Therapeutics AG is based in Vienna, Austria.
Chemistry Pharmaceutical Industry Chemical Compounds Organic Compounds Antibiotics Alcohols Infections Antibiotic Skin And Skin Structure Infections Pneumonia Community Acquired Bacterial Pneumonia Thioethers
Is NBRV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.05
52 Week Low 1.12
Average Volume 787,449
200-Day Moving Average 2.5412
50-Day Moving Average 2.1866
20-Day Moving Average 2.4945
10-Day Moving Average 2.849
Average True Range 0.1764
ADX 49.91
+DI 38.1599
-DI 11.5788
Chandelier Exit (Long, 3 ATRs ) 2.7408
Chandelier Exit (Short, 3 ATRs ) 2.4392
Upper Bollinger Band 3.3038
Lower Bollinger Band 1.6852
Percent B (%b) 0.82
BandWidth 64.886751
MACD Line 0.2773
MACD Signal Line 0.2136
MACD Histogram 0.0637
Fundamentals Value
Market Cap 80.78 Million
Num Shares 26.8 Million
EPS -11.49
Price-to-Earnings (P/E) Ratio -0.26
Price-to-Sales 24.71
Price-to-Book 3.00
PEG Ratio -0.04
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.39
Resistance 3 (R3) 3.39 3.27 3.32
Resistance 2 (R2) 3.27 3.17 3.27 3.30
Resistance 1 (R1) 3.14 3.12 3.08 3.14 3.28
Pivot Point 3.02 3.02 2.99 3.02 3.02
Support 1 (S1) 2.89 2.92 2.83 2.89 2.74
Support 2 (S2) 2.77 2.87 2.77 2.72
Support 3 (S3) 2.64 2.77 2.70
Support 4 (S4) 2.64